ORIENTBIO Inc. Capital Reinvestment Ratio
ORIENTBIO Inc. capital reinvestment ratio. ORIENTBIO Inc. (002630) has a Capital Reinvestment Ratio of 0.26x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.77 Billion) in capital expenditures (₩452.25 Million). Check ORIENTBIO Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ORIENTBIO Inc. (2007–2025)
Capital reinvestment ratio of ORIENTBIO Inc. from 2007 to 2025. This chart tracks ORIENTBIO Inc.'s Capital Reinvestment Ratio across 12 annual periods. Also explore 002630 net asset momentum to track the company's year-over-year net asset growth rate.
ORIENTBIO Inc. Capital Reinvestment Ratio by Year (2007–2025)
ORIENTBIO Inc. capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see 002630 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.37x | ₩752.29 Million | ₩4.79 Billion | ▲ +2484.5% |
| 2024 | 0.25x | ₩3.76 Billion | ₩925.25 Million | ▼ -41.2% |
| 2023 | 0.42x | ₩1.16 Billion | ₩485.64 Million | ▼ -55.5% |
| 2022 | 0.94x | ₩2.35 Billion | ₩2.21 Billion | ▲ +3107.8% |
| 2021 | 0.03x | ₩8.74 Billion | ₩256.16 Million | ▼ -99.8% |
| 2016 | 15.85x | ₩912.43 Million | ₩14.46 Billion | ▲ +397.2% |
| 2015 | 3.19x | ₩1.60 Billion | ₩5.11 Billion | ▼ -33.7% |
| 2014 | 4.81x | ₩2.17 Billion | ₩10.43 Billion | ▲ +29.3% |
| 2013 | 3.72x | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩1.52 Billion | ₩12.30 Billion | — |